🇺🇸 FDA
Patent

US 6518242

Derivatives of glycopeptide antibacterial agents

expired A61KA61K38/00

Quick answer

US patent 6518242 (Derivatives of glycopeptide antibacterial agents) held by Theravance, Inc. expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00